Angela Castela - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Angela Castela

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Diabetes, Obesity & Metabolism|June 2, 2020

Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetesAlexandra Coomans de Brachène, Angela Castela, Anne Op de Beeck, et al.

Ebiomedicine|October 2, 2018

PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 inductionMaikel L Colli, Jessica L E Hill, Laura Marroquí, et al.

Biorxiv : the Preprint Server for Biology|May 20, 2024

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.

Diabetologia|February 27, 2024

Interferons are key cytokines acting on pancreatic islets in type 1 diabetesAlexandra Coomans de Brachène, Maria Ines Alvelos, Florian Szymczak, et al.

Ebiomedicine|May 7, 2025

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.

Nature Communications|May 24, 2020

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cellsMaikel L Colli, Mireia Ramos-Rodríguez, Ernesto S Nakayasu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Diabetes, Obesity & Metabolism|June 2, 2020

Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetesAlexandra Coomans de Brachène, Angela Castela, Anne Op de Beeck, et al.

Ebiomedicine|October 2, 2018

PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 inductionMaikel L Colli, Jessica L E Hill, Laura Marroquí, et al.

Biorxiv : the Preprint Server for Biology|May 20, 2024

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.

Diabetologia|February 27, 2024

Interferons are key cytokines acting on pancreatic islets in type 1 diabetesAlexandra Coomans de Brachène, Maria Ines Alvelos, Florian Szymczak, et al.

Ebiomedicine|May 7, 2025

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Olivia Ballew, Chih-Chun Lee, et al.

Nature Communications|May 24, 2020

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cellsMaikel L Colli, Mireia Ramos-Rodríguez, Ernesto S Nakayasu, et al.

Pageof 2